Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study

M Mushfiqur Rahman1, Jacek A Kopec, Aslam H Anis

  • 1University of British Columbia, Vancouver, and Arthritis Research Centre of Canada, Richmond, British Columbia, Canada.

Insights

Osteoarthritis (OA) is linked to a higher risk of cardiovascular disease (CVD), especially for older men and adult women. This includes increased risks for ischemic heart disease (IHD) and congestive heart failure (CHF).

Area of Science:

  • Cardiology
  • Rheumatology
  • Epidemiology

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease.
  • Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality.
  • The relationship between OA and CVD risk requires further investigation.

Purpose of the Study:

  • To investigate the association between osteoarthritis and the risk of developing cardiovascular disease.
  • To determine if OA is an independent predictor of CVD events.
  • To analyze CVD risk stratification based on age and sex in OA patients.

Main Methods:

  • Utilized population-based administrative data from British Columbia, Canada (1991-2009).
  • Analyzed a cohort of 12,745 OA cases and matched non-OA controls.
  • Employed Cox proportional hazards and Poisson regression models for risk estimation, adjusting for covariates.

Main Results:

  • Osteoarthritis was identified as an independent predictor of CVD.
  • Adjusted relative risks (RRs) for CVD were elevated in older men (1.15), younger women (1.26), and older women (1.17).
  • Significant increases in risk for ischemic heart disease (IHD) and congestive heart failure (CHF) were observed, particularly in specific age-sex strata. OA patients undergoing total joint replacement showed a 26% increased CVD risk.

Conclusions:

  • This study suggests a significant association between osteoarthritis and an increased risk of cardiovascular disease.
  • Older men and adult women with OA face a heightened risk, particularly for IHD and CHF.
  • Further research is warranted to confirm these findings and explore underlying biological mechanisms.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...